VYNE Therapeutics Inc VYNE Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
VYNE Therapeutics Inc (VYNE)
VYNE Therapeutics Inc (VYNE) Financials

VYNE Therapeutics Inc (VYNE)

3.03

0.13

(4.48%)

Closed 24 November 8:00AM

Delayed by 15 minutes

3.1699

0.1399

(4.62%)

After Hours: 11:17AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-32.74	-53.39	-49.755	-67.279	-295.905	-91.212	-43.06	-41.103
Return on Equity (%)	61.982	67.247	-140.286	-74.116	-482.686	-170.277	-58.143	-47.445
Return on Invested Capital (%)	51.296	-630.443	-60.794	-76.807	-294.161	-121.279	-92.649	-50.38
Operating Margin (%)	-2087.24	-634.57	-483.506	N/A	-1197.714	-461.993	-7113.627	-6573.585
Net Profit Margin (%)	-2087.24	-634.57	-483.506	N/A	-1218.625	-496.977	-4865.828	-6710.377
Book Value Per Share	-5.576	9.868	5.612	2.807	0.868	0.908	9.725	6.358
Earnings Per Share	-2.664	-5.487	-2.214	-3.02	-5.921	-1.369	-7.186	-2.039
Cash Per Share	0.763	1.926	2.131	1.261	1.332	0.789	9.569	2.194
Working Capital Per Share	5.234	10.576	5.594	2.773	1.523	0.836	8.957	6.336
Operating Profit Per Share	0.128	0.865	0.458	N/A	0.462	0.215	0.148	0.03
EBIT Per Share	-2.664	-5.487	-2.214	-3.02	-5.921	-1.377	-10.505	-1.997
EBITDA Per Share	-2.664	-5.487	-2.214	-3.02	-5.921	-1.377	-10.505	-1.997
Free Cash Flow Per Share	-2.659	-5.483	-2.209	-3.022	-5.926	-1.371	-7.208	-2.039

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	5.28M	5.3M	23.23M	24.4M	43.21M	53.58M	3.23M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	58.04M	3.23M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-5668.687	N/A	N/A	N/A	-6368.367	N/A
Net Profit Margin (%)	N/A	N/A	-5678.788	N/A	N/A	N/A	-6376.531	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	42.78M
Price to Earnings Ratio	-1.57
Price to Sales Ratio	105.57
Price to Cash Ratio	1.46
Price to Book Ratio	0.5
Dividend Yield	-

Share Statistics

Shares Outstanding	14.75M
Average Volume (1 week)	74.11k
Average Volume (1 Month)	111.68k
52 Week Change	-20.55%
52 Week High	4.09
52 Week Low	1.57

More Ratios Coming Soon!

VYNE Therapeutics

Fintech Ecosystem Develo...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions